These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 38798277)

  • 1. Patient-reported outcome measures in surgical patients with upper gastrointestinal cancers: A qualitative interview study.
    Cass SH; Williams LA; Rajaram R; Hirata Y; Rice D; Tzeng CD; Katz MHG; Badgwell BD; Wang XS; Ikoma N
    J Surg Oncol; 2024 Jul; 130(1):117-124. PubMed ID: 38798277
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Validation and application of a module of the MD Anderson Symptom Inventory for measuring perioperative symptom burden in patients with gynecologic cancer (the MDASI-PeriOp-GYN).
    Wang XS; Shi Q; Williams LA; Cleeland CS; Garcia-Gonzalez A; Chen TY; Shahid DR; Ramirez PT; Iniesta MD; Siverand AM; Meyer LA
    Gynecol Oncol; 2019 Mar; 152(3):492-500. PubMed ID: 30876494
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Modification of existing patient-reported outcome measures: qualitative development of the MD Anderson Symptom Inventory for malignant pleural mesothelioma (MDASI-MPM).
    Williams LA; Whisenant MS; Mendoza TR; Haq S; Keating KN; Cuffel B; Cleeland CS
    Qual Life Res; 2018 Dec; 27(12):3229-3241. PubMed ID: 30187393
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Validation and Application of the MD Anderson Symptom Inventory for Traditional Chinese Medicine (MDASI-TCM).
    Li Z; Shi Q; Liu M; Jia L; He B; Yang Y; Liu J; Lin H; Lin HK; Li P; Wang XS
    J Natl Cancer Inst Monogr; 2017 Nov; 2017(52):. PubMed ID: 29140491
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Validation and application of a module of the M. D. Anderson Symptom Inventory for measuring multiple symptoms in patients with gastrointestinal cancer (the MDASI-GI).
    Wang XS; Williams LA; Eng C; Mendoza TR; Shah NA; Kirkendoll KJ; Shah PK; Trask PC; Palos GR; Cleeland CS
    Cancer; 2010 Apr; 116(8):2053-63. PubMed ID: 20166216
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Postoperative sepsis in cancer patients undergoing major elective digestive surgery is associated with increased long-term mortality.
    Mokart D; Giaoui E; Barbier L; Lambert J; Sannini A; Chow-Chine L; Brun JP; Faucher M; Guiramand J; Ewald J; Bisbal M; Blache JL; Delpero JR; Leone M; Turrini O
    J Crit Care; 2016 Feb; 31(1):48-53. PubMed ID: 26507291
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Capturing the patient's experience: using qualitative methods to develop a measure of patient-reported symptom burden: an example from ovarian cancer.
    Williams LA; Agarwal S; Bodurka DC; Saleeba AK; Sun CC; Cleeland CS
    J Pain Symptom Manage; 2013 Dec; 46(6):837-45. PubMed ID: 23615044
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Outcomes of Complex Gastrointestinal Cancer Resection at US News & World Report Top-Ranked vs Non-Ranked Hospitals.
    Tay E; Gambhir S; Stopenski S; Hohmann S; Smith BR; Daly S; Hinojosa MW; Nguyen NT
    J Am Coll Surg; 2021 Jul; 233(1):21-27.e1. PubMed ID: 33752982
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-Term Quality of Life After Total Gastrectomy Versus Ivor Lewis Esophagectomy.
    Jezerskyte E; Saadeh LM; Hagens ERC; Sprangers MAG; Noteboom L; van Laarhoven HWM; Eshuis WJ; van Berge Henegouwen MI; Gisbertz SS
    World J Surg; 2020 Mar; 44(3):838-848. PubMed ID: 31732762
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development of a patient-reported outcome tool for assessing symptom burden during perioperative care in liver surgery: The MDASI-PeriOp-Hep.
    Wang XS; Shi Q; Williams LA; Lillemoe HA; Chen TY; Gottumukkala V; Garcia-Gonzalez A; Malveaux D; Kamal M; Cleeland CS; Aloia TA
    Eur J Oncol Nurs; 2021 Jun; 52():101959. PubMed ID: 33964632
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gastrointestinal Symptoms After Resection of Esophagogastric Cancer: A Longitudinal Study on Their Incidence and Impact on Patient-Reported Outcomes.
    van Erning FN; Nieuwenhuijzen GAP; van Laarhoven HWM; Rosman C; Gisbertz SS; Heisterkamp J; Lagarde SM; Slingerland M; van den Berg JW; Kouwenhoven EA; Verhoeven RHA; Vissers PAJ
    Ann Surg Oncol; 2023 Dec; 30(13):8203-8215. PubMed ID: 37523120
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Measuring symptom burden in patients with cancer during a pandemic: the MD Anderson symptom inventory for COVID-19 (MDASI-COVID).
    Williams LA; Whisenant MS; Mendoza TR; Peek AE; Malveaux D; Griffin DK; Ponce DA; Granwehr BP; Sheshadri A; Hutcheson KA; Ali SM; Peterson SK; Heymach JV; Cleeland CS; Subbiah IM
    J Patient Rep Outcomes; 2023 May; 7(1):48. PubMed ID: 37237077
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-Term Survival in Patients with Gastroesophageal Junction Cancer Treated with Preoperative Therapy: Do Thoracic and Abdominal Approaches Differ?
    Kneuertz PJ; Hofstetter WL; Chiang YJ; Das P; Blum M; Elimova E; Mansfield P; Ajani J; Badgwell B
    Ann Surg Oncol; 2016 Feb; 23(2):626-32. PubMed ID: 26564243
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Surgeon Volume and Cancer Esophagectomy, Gastrectomy, and Pancreatectomy: A Population-based Study in England.
    Mamidanna R; Ni Z; Anderson O; Spiegelhalter SD; Bottle A; Aylin P; Faiz O; Hanna GB
    Ann Surg; 2016 Apr; 263(4):727-32. PubMed ID: 26501701
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The validity and utility of the M. D. Anderson Symptom Inventory in patients with breast cancer: evidence from the symptom outcomes and practice patterns data from the eastern cooperative oncology group.
    Mendoza TR; Zhao F; Cleeland CS; Wagner LI; Patrick-Miller LJ; Fisch MJ
    Clin Breast Cancer; 2013 Oct; 13(5):325-34. PubMed ID: 23816985
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development and validation of a symptom scale to evaluate postoperative patients with esophagogastric cancer.
    Honda M; Wakita T; Onishi Y; Nunobe S; Hiki N; Miura A; Nishigori T; Kusanagi H; Yamamoto T; Kobayashi K; Boddy A; Fukuhara S
    J Am Coll Surg; 2014 Nov; 219(5):895-903. PubMed ID: 25241187
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Highlights of the EORTC St. Gallen International Expert Consensus on the primary therapy of gastric, gastroesophageal and oesophageal cancer - differential treatment strategies for subtypes of early gastroesophageal cancer.
    Lutz MP; Zalcberg JR; Ducreux M; Ajani JA; Allum W; Aust D; Bang YJ; Cascinu S; Hölscher A; Jankowski J; Jansen EP; Kisslich R; Lordick F; Mariette C; Moehler M; Oyama T; Roth A; Rueschoff J; Ruhstaller T; Seruca R; Stahl M; Sterzing F; van Cutsem E; van der Gaast A; van Lanschot J; Ychou M; Otto F;
    Eur J Cancer; 2012 Nov; 48(16):2941-53. PubMed ID: 22921186
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Perioperative chemotherapy vs. neoadjuvant chemoradiation in gastroesophageal junction adenocarcinoma : A population-based evaluation of the Munich Cancer Registry.
    Münch S; Habermehl D; Agha A; Belka C; Combs SE; Eckel R; Friess H; Gerbes A; Nüssler NC; Schepp W; Schmid RM; Schmitt W; Schubert-Fritschle G; Weber B; Werner J; Engel J
    Strahlenther Onkol; 2018 Feb; 194(2):125-135. PubMed ID: 29071366
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Validating the M. D. Anderson Symptom Inventory (MDASI) for use in patients with ovarian cancer.
    Sailors MH; Bodurka DC; Gning I; Ramondetta LM; Williams LA; Mendoza TR; Agarwal S; Sun CC; Cleeland CS
    Gynecol Oncol; 2013 Aug; 130(2):323-8. PubMed ID: 23685012
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diffuse-Type Histology Is Prognostic for All Siewert Types of Gastroesophageal Adenocarcinoma.
    Mahuron KM; Sullivan KM; Hernandez MC; Chen YJ; Chao J; Melstrom LG; Paz IB; Kim JY; Mannan R; Lin JL; Fong Y; Woo Y
    J Gastric Cancer; 2024 Jul; 24(3):267-279. PubMed ID: 38960886
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.